KBC Group NV Sells 161,372 Shares of Colgate-Palmolive (NYSE:CL)

KBC Group NV reduced its stake in shares of Colgate-Palmolive (NYSE:CLFree Report) by 19.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 653,635 shares of the company’s stock after selling 161,372 shares during the quarter. KBC Group NV owned about 0.08% of Colgate-Palmolive worth $67,854,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. Huntington National Bank increased its holdings in shares of Colgate-Palmolive by 10.3% in the third quarter. Huntington National Bank now owns 172,829 shares of the company’s stock worth $17,941,000 after purchasing an additional 16,121 shares during the last quarter. D Orazio & Associates Inc. increased its stake in Colgate-Palmolive by 3.9% in the 3rd quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock worth $297,000 after acquiring an additional 108 shares during the last quarter. Kovack Advisors Inc. raised its holdings in shares of Colgate-Palmolive by 4.8% during the 3rd quarter. Kovack Advisors Inc. now owns 4,450 shares of the company’s stock worth $462,000 after acquiring an additional 202 shares in the last quarter. Oppenheimer & Co. Inc. boosted its position in shares of Colgate-Palmolive by 4.3% during the 3rd quarter. Oppenheimer & Co. Inc. now owns 36,718 shares of the company’s stock valued at $3,812,000 after acquiring an additional 1,501 shares during the last quarter. Finally, GHE LLC grew its holdings in shares of Colgate-Palmolive by 1.6% in the third quarter. GHE LLC now owns 20,938 shares of the company’s stock valued at $2,138,000 after purchasing an additional 338 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Insider Activity at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the firm’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.34% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several research firms have commented on CL. Sanford C. Bernstein increased their price objective on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the company a “market perform” rating in a research report on Tuesday, July 30th. Wells Fargo & Company lowered their price target on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating for the company in a report on Monday, October 28th. TD Cowen reduced their price objective on Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating on the stock in a research note on Monday, October 28th. Barclays raised their price objective on Colgate-Palmolive from $91.00 to $96.00 and gave the company an “equal weight” rating in a research note on Monday, July 29th. Finally, Evercore ISI increased their price target on Colgate-Palmolive from $100.00 to $106.00 and gave the company an “outperform” rating in a report on Thursday, July 18th. One analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $105.11.

Get Our Latest Research Report on Colgate-Palmolive

Colgate-Palmolive Stock Down 0.5 %

Shares of Colgate-Palmolive stock opened at $91.08 on Thursday. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The stock has a market cap of $74.41 billion, a price-to-earnings ratio of 26.10, a PEG ratio of 3.27 and a beta of 0.42. The firm’s 50-day moving average is $100.30 and its two-hundred day moving average is $98.53. Colgate-Palmolive has a 1 year low of $75.17 and a 1 year high of $109.30.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.20%. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.